THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices
Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on… Read More
© 2026 CSRXP- All Rights Reserved
Lawmakers Keeping Up Bipartisan Momentum On Drug Pricing
House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
Part IV: Big Pharma’s Tax Conundrum The average American spends $1… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
Part III: As Prices Rise, So Too Does Ad Spending The average American… Read More
CSRxP: House Passage of Bipartisan CREATES Act a Pivotal Moment for Patients
Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
Part II: An Industry Booming Off of Price-Gouging The average American spends… Read More
CSRxP Encourages U.S. House of Representatives to Pass Bipartisan CREATES Act
Commends Lawmakers of Both Parties for Working Together to Advance Key Drug… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
Part I: The Math Undercuts the R&D Defense The average American spends… Read More
CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D
Analysis Finds Industry Spending on Advertising, Overhead and Profits More… Read More
CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington… Read More
THEY SAID IT! House Energy & Commerce Lawmakers Roast Big Pharma, Pledge Bipartisan Action and Question the Rebate Rule
Washington, D.C. – The House Energy & Commerce Subcommittee on Health… Read More